Aestis, Inc. Introduces An Innovative, Non-Invasive Treatment And Prevention Of Obesity Using Controlled Hypoxia

BOULDER, Colo.--(BUSINESS WIRE)--June 21, 2006--Aestis, Inc., the developers of the ThinAir(TM) system, a controlled hypoxia treatment of obesity, announces that they will be presenting at the In3 Medical Device Summit on Thursday June 22, 2006, at 3:30 p.m. PDT. The conference, sponsored by Medtech Insight, will be held at The Palace Hotel in San Francisco, CA, from June 21 - 23, 2006. Investors and researchers interested in learning more about this non-invasive treatment for the obese and overweight are invited to attend.
MORE ON THIS TOPIC